HANNAH HUBER: Open Payments
NPI 1346869112 · DANVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 16 payments from 14 companies in 2025. Trend: 2023 $586 · 2024 $87 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| Astellas Pharma US Inc | 2 | $33 |
| Organon LLC | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Hologic Sales and Service, LLC | 1 | $22 |
| Minerva Surgical, Inc | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Biogen, Inc. | 1 | $21 |
| SHIELD THERAPEUTICS INC | 1 | $17 |
| Boston Scientific Corporation | 1 | $16 |
Products named: CAPLYTA, Veozah, NEXPLANON, Kerendia, MYOSURE TISSUE REMOVAL DEVICE, MYFEMBREE, ZURZUVAE, ACCRUFER.
Industry payments across IN — which companies pay providers there.
